Identifying key parts of viruses that could cause pandemics
Official title: THE IDENTIFICATION AND VALIDATION OF EPITOPES CONSERVED IN VIRAL PATHOGEN FAMILIES WITH PANDEMIC POTENTIAL
Funded at La Jolla Institute for Immunology · NIH-11203574 · Data updated 2026-11-12
This study is looking for common parts of certain viruses that could help create vaccines or treatments for future pandemics, so that people can be better protected against illnesses like COVID-19 and others.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | La Jolla Institute for Immunology NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project start | September 30, 2024 |
| Project end | September 29, 2025 |
| Funding year | 2024 |
| Award (this year) | $1,124,982 |
| NIH project number | 75N93024C00056-0-9999-1 |
| Project ID | NIH-11203574 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at risk for infections from viruses like SARS-CoV-2, Dengue, Chikungunya, Measles, Lassa, and Poliovirus.
✕Less likely to help
Patients who are not at risk for these specific viral infections may not receive direct benefits from this research.
What this research studies
This research focuses on identifying and validating specific parts of viruses that are common across families known to have pandemic potential. By selecting prototype viruses from families such as Coronaviridae, Flaviviridae, and others, the research aims to screen for these conserved epitopes. This could help in developing vaccines or treatments that are effective against multiple viruses within these families. Patients may benefit from advancements in vaccine development and improved preparedness for future pandemics.
Why it matters
Potential benefit: If successful, this research could lead to the development of vaccines that protect against multiple viral infections with pandemic potential.
How similar studies have gone: Other research has shown success in identifying conserved viral epitopes, indicating that this approach has potential for significant advancements in pandemic preparedness.
Where this research is happening
-
La Jolla Institute for Immunology
La Jolla, United States Active
Researchers
- Principal investigator: Fabritzky, Brandon — La Jolla Institute for Immunology
- Study coordinator: Fabritzky, Brandon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.